 |
 |

Statin Use and Sepsis in Patients With Chronic Kidney Disease
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Gupta and colleagues1 found that the use of statins was independently associated with reduction in the risk of hospitalization for sepsis in patients with chronic kidney disease receiving dialysis. Several potential underlying mechanisms were invoked to explain an effect of statins, and we would like to add another possibility.
Statins increase the level of apolipoprotein (apo) A-I, the major protein component of high-density lipoprotein cholesterol, as well as the ratio of apo A-I to apo B.2 Apolipoprotein A-I has the ability to bind and clear lipopolysaccharide (endotoxin) and thereby protect against further lipopolysaccharide-induced cytokine activation.3 Furthermore, apo A-I can specifically block the interaction between activated T lymphocytes and monocytes, inhibiting production of tumor necrosis factor and interleukin 1 in monocytes in the serum of healthy volunteers.4 As a clinical equivalent of this laboratory finding, we showed that a low serum level of apo A-I in critically . . . [Full Text of this Article]
Catherine Chenaud, MD;
Paolo Merlani, MD
paolo.merlani@hcuge.ch Intensive Care Service Department of Anesthesiology, Pharmacology and Intensive Care University of Geneva Hospitals Geneva, Switzerland
RELATED LETTER
Statin Use and Sepsis in Patients With Chronic Kidney DiseaseReply
Rajesh Gupta, Laura C. Plantinga, Josef Coresh, and Neil R. Powe
JAMA. 2007;298(3):284-285.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
Rajesh Gupta, Laura C. Plantinga, Nancy E. Fink, Michal L. Melamed, Josef Coresh, Caroline S. Fox, Nathan W. Levin, and Neil R. Powe
JAMA. 2007;297(13):1455-1464.
ABSTRACT
| FULL TEXT
|